These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11918566)
1. Chronic relapsing thrombotic thrombocytopenic purpura due to a deficiency of von Willebrand factor-cleaving protease activity. Stark GL; Wallis JP; Allford SL; Hanley J Br J Haematol; 2002 Apr; 117(1):251-2. PubMed ID: 11918566 [No Abstract] [Full Text] [Related]
2. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245 [TBL] [Abstract][Full Text] [Related]
3. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura. Furlan M; Lämmle B Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823 [TBL] [Abstract][Full Text] [Related]
4. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. Barbot J; Costa E; Guerra M; Barreirinho MS; Isvarlal P; Robles R; Gerritsen HE; Lämmle B; Furlan M Br J Haematol; 2001 Jun; 113(3):649-51. PubMed ID: 11380451 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. Tsai HM; Lian EC N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246 [TBL] [Abstract][Full Text] [Related]
7. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
8. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011 [TBL] [Abstract][Full Text] [Related]
9. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency. te Loo DM; Levtchenko E; Furlan M; Roosendaal GP; van den Heuvel LP Pediatr Nephrol; 2000 Aug; 14(8-9):762-5. PubMed ID: 10955922 [TBL] [Abstract][Full Text] [Related]
10. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Tsai HM J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343 [TBL] [Abstract][Full Text] [Related]
11. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene]. Schiphorst RH; van de Kar NC; van den Heuvel LP Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551 [TBL] [Abstract][Full Text] [Related]
12. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura. Tsai HM Int J Hematol; 2002 Aug; 76 Suppl 2():132-8. PubMed ID: 12430913 [TBL] [Abstract][Full Text] [Related]
13. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura. Furlan M Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284 [TBL] [Abstract][Full Text] [Related]
14. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715 [TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. Peyvandi F; Ferrari S; Lavoretano S; Canciani MT; Mannucci PM Br J Haematol; 2004 Nov; 127(4):433-9. PubMed ID: 15521921 [TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Bianchi V; Robles R; Alberio L; Furlan M; Lämmle B Blood; 2002 Jul; 100(2):710-3. PubMed ID: 12091372 [TBL] [Abstract][Full Text] [Related]
18. [Thrombotic thrombocytopenic purpura and von Willebrand factor- specific-cleaving enzyme]. Matsumoto M; Fujimura Y Nihon Naika Gakkai Zasshi; 2000 Jun; 89(6):1137-42. PubMed ID: 10892190 [No Abstract] [Full Text] [Related]
19. [Idiopathic thrombotic thrombocytopenic purpura or Moschowitz syndrome: current physiopathologic and therapeutic perspectives]. Retornaz F; Durand JM; Poullin P; Lefèvre P; Soubeyrand J Rev Med Interne; 2000 Sep; 21(9):777-84. PubMed ID: 11039173 [TBL] [Abstract][Full Text] [Related]
20. Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2. Winkler A; Kremer Hovinga JA; Bianchi V; Studt JD; Lämmle B Hamostaseologie; 2003 Aug; 23(3):103-8. PubMed ID: 12923577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]